english.prescrire.org > Prescrire International > N°59 - June 2002

n°59

June 2002

Issue Contents
Editorial

Regular post-marketing evaluation is needed

p.66

New Products


Ursodeoxycholic acid, primary biliary cirrhosis: dashed hopes

p.67-69

Sertraline: may help children with obsessive-compulsive disorder

p.69-72

Obsessive-compulsive disorder: behaviour therapy and drugs are only moderately effective

p.71-72

Combined acellular pertussis vaccines: no tangible benefit in primary vaccination

p.73-75

Pertussis vaccines: choice between efficacy and tolerability

p.74-75

Sublingual apomorphine in erectile disorders: a narrow therapeutic margin

p.76-79

Tibolone and menopausal symptoms: oestrogen-progestogen combinations are still the reference treatment

p.79-82

No androgen for sexual dysfunction after menopause

p.81

Tenecteplase, another thrombolytic agent for myocardial infarction: a slightly simpler treatment

p.83-84

Topical lidocaine + prilocaine: analgesia during mechanical debridement

p.94

Oral granisetron: avoids intravenous treatment durong highly emetic chemotherapy

p.94

Risedronic acid 5 mg

p.94

Lopinavir + ritonavir: still incomplete evaluation

p.95

Hepatitis A vaccine: batches with doubtful efficacy

p.95

Adverse Effects


Coxibs + oral anticoagulants: risk of interaction

p.85-86

Renal impairment due to topical NSAIDs

p.86

Heart failure on infliximab

p.86-87

Dr bupropion and Mr amfebutamone

p.87

Severe tuberculosis while on infliximab (cont'd)

p.87

Reviews


Creatine: little impact on athletic performance, but a risk of adverse effects

p.88-90

Ecstasy and pregnancy

p.91

Vasectomy

p.94

Outlook


Missing data

p.92

Very late withdrawal of fluorides

p.92

Tackling antibiotic waste: a public health priority

p.93

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe